Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease

Archives of Neurology

Volumn 58, Issue 3, 2001, Pages 435-440

  Seshadri, S ^a   Zornberg, G L ^a   Derby, L E ^a   Myers, M W ^a   Jick, H ^a   Drachman, D A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UNITED KINGDOM;

EID: 0035107245     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.3.435     Document Type: Article

References (28)

1. Lifetime risk of dementia and Alzheimer's disease: The impact of mortality on risk estimates in the Framingham study
2. Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system
3. Estrogen and nerve growth factor-related systems in brain: Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging
4. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein
5. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: Implications for Alzheimer's disease
6. Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women
7. Estrogen replacement therapy in older women
8. Estrogen deficiency and risk of Alzheimer's disease in women
9. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
10. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging
11. Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease
12. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging
13. Estrogen use and early onset Alzheimer's disease: A population-based study
14. Postmenopausal estrogen replacement therapy and risk of AD
15. A case-control study of Alzheimer's disease in Australia
16. Estrogen replacement therapy and cognitive function in older women
17. Postmenopausal estrogen therapy and the risk of Alzheimer's disease: A population-based case-control study
18. Estrogen for Alzheimer's disease in women
19. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease
20. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study
21. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia
22. Estrogen to treat Alzheimer's disease: Too little, too late?
23. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
24. Further validation of information recorded on a general practitioner-based computerized data resource in the United Kingdom
25. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease
26. Calcium channel blockers and risk of cancer
27. Principles of epidemiologic research on adverse and beneficial drug effects
28. Low body mass index in demented outpatients